Skip to content

Clinical trials

Phase 3 Hepatitis C trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: Poland Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20073
20082
20101
20116
20127
20131
20141
20174
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Janssen R&D Ireland5
AbbVie4
GlaxoSmithKline3
Debiopharm International SA2
Human Genome Sciences Inc.2
Atea Pharmaceuticals, Inc.1
Bausch Health Americas, Inc.1
Gilead Sciences1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C28
Hepatitis C, Chronic13
Hepatitis4
Fibrosis2
Liver Diseases2
Acquired Immunodeficiency Syndrome1
HIV Infections1
Hepatitis B1
Non-alcoholic Fatty Liver Disease1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.